Arizona Sonoran Appoints Hannam & Partners as Project Finance Advisor for the Cactus Project
CASA GRANDE, Ariz. & TORONTO--(BUSINESS WIRE)--$ASCU #Arizona--Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (“ASCU 
11 months ago
KKR Provides $600 Million Financing to Indian Conglomerate Manipal Group
Transaction marks KKR’s latest and largest credit investment in IndiaMUMBAI, India--(BUSINESS WIRE)--KKR, a leading global…
11 months ago
Kenanga Investors Launches New Global Real Asset Fund
The Kenanga Alternative Series: Global Real Assets Fund offers investors exposure primarily to global real…
11 months ago
MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies
Paving the Way for European Clinical Entry and Global Technology Transfer A Milestone Partnership Highlighting…
11 months ago
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
SEOUL, South Korea--(BUSINESS WIRE)--ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced…
11 months ago
Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
MARLBOROUGH, Mass.--(BUSINESS WIRE)--#AI--SCIEX, a global leader in life science analytical technologies and operating company of…
11 months ago
Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting
- Clinically meaningful anti-tumor activity of ZL-1310 observed in heavily pretreated population of patients with…
11 months ago
James Hardie Industries plc Announces Proposed Private Offering of Senior Secured Notes
SYDNEY--(BUSINESS WIRE)--James Hardie Industries plc (ASX: JHX) (“James Hardie†or the “Companyâ€) announced today that…
11 months ago
AEye’s Apollo Lidar Sensor Wins Prestigious AIIA Intelligent Perception Industry Leadership Award
PLEASANTON, Calif.--(BUSINESS WIRE)--AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance lidar solutions, announced…
11 months ago
ENHERTU® Plus Pertuzumab Reduced the Risk of Disease Progression or Death by 44% Versus THP as First-Line Therapy in Patients with HER2 Positive Metastatic Breast Cancer in DESTINY-Breast09 Phase 3 Trial
Daiichi Sankyo and AstraZeneca’s ENHERTU plus pertuzumab showed a median progression-free survival greater than three…
11 months ago